GC
SCMP

Globeflex Capital’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Globeflex Capital’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-101,190
Closed -$1.82M – 461
2017
Q4 		$1.82M Sell
101,190
-2,759
-3% -$34K 0.51% 42
2017
Q3 		$1.23M Hold
103,949
– – 0.35% 86
2017
Q2 		$1.09M Hold
103,949
– – 0.27% 149
2017
Q1 		$1.14M Buy
103,949
+43,900
+73% +$510K 0.27% 147
2016
Q4 		$814K Buy
60,049
+47,100
+364% +$657K 0.2% 193
2016
Q3 		$159K Sell
12,949
-10,700
-45% -$126K 0.04% 347
2016
Q2 		$259K Buy
23,649
+61
+0.3% +$683 0.07% 310
2016
Q1 		$258K Sell
23,588
-42,000
-64% -$531K 0.07% 307
2015
Q4 		$1.13M Buy
65,588
+28,431
+77% +$510K 0.3% 117
2015
Q3 		$738K Sell
37,157
-4,800
-11% -$110K 0.16% 236
2015
Q2 		$689K Buy
41,957
+16,857
+67% +$292K 0.13% 280
2015
Q1 		$391K Sell
25,100
-4,759
-16% -$73.8K 0.07% 302
2014
Q4 		$426K Buy
29,859
+59
+0.2% +$623 0.08% 304
2014
Q3 		$194K Sell
29,800
-317
-1% -$2.1K 0.02% 357
2014
Q2 		$207K Sell
30,117
-80
-0.3% -$566 0.02% 356
2014
Q1 		$215K Sell
30,197
-2,600
-8% -$22.3K 0.02% 337
2013
Q4 		$308K Hold
32,797
– – 0.04% 318
2013
Q3 		$204K Buy
32,797
+229
+0.7% +$1.43K 0.03% 350
2013
Q2 		$214K Buy
+32,568
New +$258K 0.03% 362

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Globeflex Capital's SCMP Position: Q1 2018 in Review

Globeflex Capital sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 101,190 shares — an estimated $1.82M sold.

Globeflex Capital first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $1.82M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Globeflex Capital reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Globeflex Capital sold 101,190 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.82M.
  • Globeflex Capital first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
  • Globeflex Capital's Sucampo Pharmaceuticals, Inc. position peaked at $1.82M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Globeflex Capital's 13F filing for Q1 2018, filed 14 May 2018.